{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:44:40Z","timestamp":1649105080207},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00108-005-1491-9","type":"journal-article","created":{"date-parts":[[2005,9,8]],"date-time":"2005-09-08T12:30:48Z","timestamp":1126182648000},"page":"1233-1244","source":"Crossref","is-referenced-by-count":4,"title":["Polymyalgia rheumatica"],"prefix":"10.1007","volume":"46","author":[{"given":"B.","family":"Hellmich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1491_CR1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.2.1450.811","volume":"2","author":"Bruce","year":"1888","unstructured":"Bruce W (1888) Senile rheumatic gout. BMJ 2: 811\u2013813","journal-title":"BMJ"},{"key":"1491_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.16.2.230","volume":"16","author":"Barber","year":"1957","unstructured":"Barber H (1957) Myalgic syndrome with constitutional effects: polymyalgia rheumatica. Ann Rheum Dis 16: 230\u2013237","journal-title":"Ann Rheum Dis"},{"key":"1491_CR3","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/bmj.2.5212.1562","volume":"2","author":"Paulley","year":"1960","unstructured":"Paulley J, Hughes J (1960) Giant cell arteritis or arteritis of the aged. BMJ 2: 1562\u20131567","journal-title":"BMJ"},{"key":"1491_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347: 261\u2013271","journal-title":"N Engl J Med"},{"key":"1491_CR5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.berh.2004.06.003","volume":"18","author":"Salvarani","year":"2004","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG (2004) Polymyalgia rheumatica. Best Pract Res Clin Rheumatol 18: 705\u2013722","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1491_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","volume":"38","author":"Salvarani","year":"1995","unstructured":"Salvarani C, Gabriel S, O\u2019Fallon W, Hunder G (1995) Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970\u20131991. Arthritis Rheum 38: 369\u2013373","journal-title":"Arthritis Rheum"},{"key":"1491_CR7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/1529-0131(199906)42:6<1259::AID-ANR24>3.0.CO;2-I","volume":"42","author":"Salvarani","year":"1999","unstructured":"Salvarani C, Hunder G (1999) Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis. Arthritis Rheum 42: 1259\u20131266","journal-title":"Arthritis Rheum"},{"key":"1491_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/sarh.2002.50025","volume":"33","author":"Gonzalez-Gay","year":"2003","unstructured":"Gonzalez-Gay M, Amoli M, Garcia-Porrus C, Ollier WE (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33: 38\u201348","journal-title":"Semin Arthritis Rheum"},{"key":"1491_CR9","first-page":"748","volume":"29","author":"Cutolo","year":"2002","unstructured":"Cutolo M, Straub RH, Foppiani L et al. (2002) Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 29: 748\u2013756","journal-title":"J Rheumatol"},{"key":"1491_CR10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/art.1780390719","volume":"39","author":"Meliconi","year":"1996","unstructured":"Meliconi R, Pulsatelli L, Uguccioni M et al. (1996) Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum 39: 1199\u20131207","journal-title":"Arthritis Rheum"},{"key":"1491_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","volume":"199","author":"Ma-Krupa","year":"2004","unstructured":"Ma-Krupa W, Jeon MS, Spoerl S, Tedder T, Goronzy JJ, Weyand CM (2004) Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 199: 173\u2013183","journal-title":"J Exp Med"},{"key":"1491_CR12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","volume":"121","author":"Weyand","year":"1994","unstructured":"Weyand CM, Hicok KC, Hunder GG, Goronzy JJ (1994) Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 121: 484\u2013491","journal-title":"Ann Intern Med"},{"key":"1491_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","volume":"139","author":"Weyand","year":"2003","unstructured":"Weyand C, Goronzy J (2003) Giant cell arteritis and polymyalgia rheumatica. Ann Intern Med 139: 505\u2013515","journal-title":"Ann Intern Med"},{"key":"1491_CR14","doi-asserted-by":"crossref","unstructured":"Blockmans D, Maes A, Stroobants S et al. (1999) New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38: 444\u2013447","DOI":"10.1093\/rheumatology\/38.5.444"},{"key":"1491_CR15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9343(99)00424-6","volume":"108","author":"Blockmans","year":"2000","unstructured":"Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108: 246\u2013249","journal-title":"Am J Med"},{"key":"1491_CR16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W","volume":"41","author":"Salvarani","year":"1998","unstructured":"Salvarani C, Cantini F, Macchioni P et al. (1998) Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 41: 1221\u20131226","journal-title":"Arthritis Rheum"},{"key":"1491_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.20901","volume":"53","author":"Salvarani","year":"2005","unstructured":"Salvarani C, Cantini F, Niccoli L et al. (2005) Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 53: 33\u201338","journal-title":"Arthritis Rheum"},{"key":"1491_CR18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archinte.159.6.577","volume":"159","author":"Weyand","year":"1999","unstructured":"Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ (1999) Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 159: 577\u2013584","journal-title":"Arch Intern Med"},{"key":"1491_CR19","doi-asserted-by":"crossref","unstructured":"Lopez-Hoyos M, Ruiz de Alegria C, Blanco R et al. (2004) Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology (Oxford) 43: 655\u2013657","DOI":"10.1093\/rheumatology\/keh143"},{"key":"1491_CR20","first-page":"1049","volume":"28","author":"Cantini","year":"2001","unstructured":"Cantini F, Salvarani C, Olivieri I et al. (2001) Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 28: 1049\u20131055","journal-title":"J Rheumatol"},{"key":"1491_CR21","first-page":"1837","volume":"28","author":"McGonagle","year":"2001","unstructured":"McGonagle D, Pease C, Marzo-Ortega H, O\u2019Connor P, Gibbon W, Emery P (2001) Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. J Rheumatol 28: 1837\u20131841","journal-title":"J Rheumatol"},{"key":"1491_CR22","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","volume":"337","author":"Schmidt","year":"1997","unstructured":"Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337: 1336\u20131342","journal-title":"N Engl J Med"},{"key":"1491_CR23","doi-asserted-by":"crossref","unstructured":"Narvaez J, Narvaez JA, Nolla JM, Sirvent E, Reina D, Valverde J (2005) Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) 44: 479\u2013483","DOI":"10.1093\/rheumatology\/keh513"},{"key":"1491_CR24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38: 434\u2013439","journal-title":"Ann Rheum Dis"},{"key":"1491_CR25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"Chuang","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97: 672\u2013680","journal-title":"Ann Intern Med"},{"key":"1491_CR26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/ard.2004.025296","volume":"64","author":"Bird","year":"2005","unstructured":"Bird HA, Leeb BF, Montecucco CM et al. (2005) A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 64: 626\u2013629","journal-title":"Ann Rheum Dis"},{"key":"1491_CR27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.58.4.230","volume":"58","author":"Cantini","year":"1999","unstructured":"Cantini F, Salvarani C, Niccoli L (1999) Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: a prospective follow-up and magnetic resonance imaging study. Ann Rheum Dis 58: 230\u2013236","journal-title":"Ann Rheum Dis"},{"key":"1491_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4065\/79.4.483","volume":"79","author":"Younge","year":"2004","unstructured":"Younge BR, Cook BE Jr, Bartley GB, Hodge DO, Hunder GG (2004) Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc 79: 483\u2013491","journal-title":"Mayo Clin Proc"},{"key":"1491_CR29","first-page":"1484","volume":"27","author":"Chevalet","year":"2000","unstructured":"Chevalet P, Barrier JH, Pottier P et al. (2000) A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol 27: 1484\u20131491","journal-title":"J Rheumatol"},{"key":"1491_CR30","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","volume":"339","author":"Gabriel","year":"1997","unstructured":"Gabriel SE, Sunku J, Salvarani C (1997) Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 339: 1873\u20131878","journal-title":"Arthritis Rheum"},{"key":"1491_CR31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","volume":"141","author":"Caporali","year":"2004","unstructured":"Caporali R, Cimmino M, Ferracioloi G et al. (2004) Prednisone plus methotrexate for polymyalgia rheumatica. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 141: 493\u2013500","journal-title":"Ann Intern Med"},{"key":"1491_CR32","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1055\/s-2003-45204","volume":"128","author":"Gross","year":"2003","unstructured":"Gross WL, Hellmich B (2003) Horton\u2019s Temporal Arteritis (Riesenzellarteritis). Pionierarbeit und aktueller Stand. Dtsch Med Wochenschr 128: 2604\u20132607","journal-title":"Dtsch Med Wochenschr"},{"key":"1491_CR33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","volume":"46","author":"Hoffman","year":"2002","unstructured":"Hoffman GS, Cid MC, Hellmann DB et al. (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46: 1309\u20131318","journal-title":"Arthritis Rheum"},{"key":"1491_CR34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","volume":"134","author":"Jover","year":"2001","unstructured":"Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 134: 106\u2013114","journal-title":"Ann Intern Med"},{"key":"1491_CR35","first-page":"760","volume":"30","author":"Salvarani","year":"2003","unstructured":"Salvarani C, Cantini F, Niccoli L et al. (2003) Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol 30: 760\u2013763","journal-title":"J Rheumatol"},{"key":"1491_CR36","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","volume":"50","author":"Nesher","year":"2004","unstructured":"Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50: 1332\u20131337","journal-title":"Arthritis Rheum"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-005-1491-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-005-1491-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-005-1491-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:33Z","timestamp":1558584693000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-005-1491-9"}},"subtitle":["Myalgisches Syndrom oder okkulte Vaskulitis?"],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1007\/s00108-005-1491-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}